News for 'life-sciences'

Reliance Life to set up hospitals, make drugs

Reliance Life to set up hospitals, make drugs

Rediff.com2 Feb 2007

Reliance Life Sciences is planning to invest at least Rs 1,000 crore (Rs 10 billion) to set up hospitals in the country's metros and dispensaries in small towns.

PE/VC investments hit 12-quarter low at $5.1 billion

PE/VC investments hit 12-quarter low at $5.1 billion

Rediff.com28 Apr 2020

The quarter also saw exits worth $1.9 billion across 37 deals, 59 per cent higher YoY. This was driven by one of India's largest PE-backed IPO exit, the $1-billion partial exit by Carlyle in the SBI Cards IPO.

PGD in clinical research

PGD in clinical research

Rediff.com8 Nov 2005

The Institute of Clinical Research invites applications for its one-year, part-time Post-graduate Diploma in Clinical Research.

COVID vaccine likely to be available by first of 2021: Choubey

COVID vaccine likely to be available by first of 2021: Choubey

Rediff.com19 Sep 2020

Responding to another question, Choubey said that the phase-I of clinical trials have revealed excellent safety of the two candidate vaccines indigenously developed by Bharat Biotech in collaboration with Indian Council of Medical Research and Cadila Healthcare Ltd, and now their immunogenicity testing is in progress. Their phase II clinical trials are ongoing.

Birth of a leader: The inspiring story of Wipro's Senior VP

Birth of a leader: The inspiring story of Wipro's Senior VP

Rediff.com23 Dec 2013

Sangita Singh, senior VP and head of Wipro's global IT business strategic unit shares key moments from her 21-year-old career journey and offers lessons in leadership for young professionals.

$250-mn drug fund by TCG

$250-mn drug fund by TCG

Rediff.com7 Oct 2005

New Covid variant: Scientists warn against more mutations

New Covid variant: Scientists warn against more mutations

Rediff.com22 Dec 2020

Over time, as more mutations occur, the vaccine may need to be altered.

'We are trying to conquer space, and we don't have tigers and elephants'

'We are trying to conquer space, and we don't have tigers and elephants'

Rediff.com31 Dec 2013

Vinodini Jayaraman began painting as a way to help her get over a frustrating stutter early in life. Now her work, an ode to conservation, covers a 100-foot wall at the University of Memphis.

Srikant Datar, 2nd Indian to be named Dean of Harvard Business School

Srikant Datar, 2nd Indian to be named Dean of Harvard Business School

Rediff.com10 Oct 2020

Eminent Indian-origin academician Srikant Datar has been named as Dean of Harvard Business School, succeeding Nitin Nohria and becoming the second consecutive dean hailing from India to lead the prestigious 112-year-old institution. Datar, an alumnus of University of Bombay and Indian Institute of Management, Ahmedabad, is the Arthur Lowes Dickinson Professor of Business Administration and the senior associate dean for University Affairs at Harvard Business School (HBS). He will assume charge as the school's next dean on January 1, president Larry Bacow said.

TCS forays into drug discovery

TCS forays into drug discovery

Rediff.com7 Mar 2005

TCS Q3 profit surges 50%, beats estimates

TCS Q3 profit surges 50%, beats estimates

Rediff.com16 Jan 2014

Tata Consultancy Services said quarterly consolidated net profit surged 49.6 percent, its fastest pace of increase in at least two-and-half years, helped by increasing demand for outsourcing services in the United States and Europe.

20 passengers from UK test positive for COVID-19

20 passengers from UK test positive for COVID-19

Rediff.com22 Dec 2020

According to SOP, those testing positive will be isolated in a separate unit of an institutional facility.

Health ministry okays HCQ for early course of COVID-19

Health ministry okays HCQ for early course of COVID-19

Rediff.com13 Jun 2020

The health ministry on Saturday recommended the use of antiviral drug remdesivir in moderate stage of COVID-19 while backtracking from its earlier stance on hydroxychloroquine, saying the anti-malarial drug should be used in the early course of the disease and not on critically ill patients.

How Odisha is winning the coronavirus fight

How Odisha is winning the coronavirus fight

Rediff.com14 Apr 2020

From announcing a lockdown and extending its tenure, setting up the country's first two exclusive Covid-19 hospitals, creating a hotspot zone, providing doorstep medical service and making masks compulsory, the state is doing all it can to dwarf the virus.

Maharashtra in talks with IBM

Maharashtra in talks with IBM

Rediff.com22 Aug 2003

IT services, pharma could drive hiring in 2013

IT services, pharma could drive hiring in 2013

Rediff.com27 Dec 2012

In 2012, employers looked most for professionals in IT or software services, FMCG industries and BPO or ITES, followed by real estate and pharmaceuticals or life sciences to fill mid or senior positions.

'COVID-19 is not food-borne'

'COVID-19 is not food-borne'

Rediff.com20 Mar 2020

'It is safe to consume cooked non-vegetarian food.'

Employees may see 11.3% pay hike

Employees may see 11.3% pay hike

Rediff.com23 Apr 2013

India Inc is expected to offer average salary increments of 11.3 per cent this fiscal and those working in sectors like pharmaceuticals, health care and life sciences are expected to get a raise of 13.1 per cent.

Deal Street dazzles thanks to Reliance's equity divestment

Deal Street dazzles thanks to Reliance's equity divestment

Rediff.com30 Dec 2020

Record equity divestment by the Reliance Group in its telecom and retail businesses garnering around $23 billion revved up the deal street in 2020, which otherwise would have gone down as one of the dullest on record, and dealmakers are seeing sunnier days in 2021 given the large scope for consolidation in a slew of sectors ravaged by the pandemic. With Jio Platforms alone garnering over $16 billion (Rs 1,18,318 crore) by selling 25.24 per cent stake and Reliance Retail notching up $6.4 billion (Rs 47,265 crore) by divesting around 9 per cent shareholding, the deal street signed off with $85 billion in the deal kitty across 1,270 transactions. This is higher by about 10 per cent over 2019. What is significant is that over a third of the total deal value came from Reliance transactions, say investment bankers.

Infosys Science Foundation honours winners

Infosys Science Foundation honours winners

Rediff.com10 Jan 2012

Former President A P J Abdul Kalam felicitated the six winners.

Wipro to acquire US-based HealthPlan Services for $460 mn

Wipro to acquire US-based HealthPlan Services for $460 mn

Rediff.com11 Feb 2016

Wipro's clients currently include over 100 US payers, healthcare providers, and public health agencies.

Titan, a good bet for Rakesh Jhunjhunwala

Titan, a good bet for Rakesh Jhunjhunwala

Rediff.com9 Aug 2019

Titan accounted for 59.6 per cent of his disclosed portfolio at Rs 8,355 crore. This is more than 10 times the next biggest holding, Federal Bank, at Rs 619 crore.

Toronto invites Indian investments

Toronto invites Indian investments

Rediff.com4 May 2011

A visiting trade delegation from Toronto, which met with local entrepreneurs and investors here on Tuesday, said it would focus on attracting investments into information and communication technology, life sciences and renewable energy sectors.

A peek into the stocks that Jhunjhunwala is invested in

A peek into the stocks that Jhunjhunwala is invested in

Rediff.com26 Apr 2019

Jhunjhunwala increases stake in DHFL, luggage maker VIP Industries and pharma major Lupin but is cautious on auto holding. At the end of the March quarter, Jhunjhunwala held positions in 29 firms.

The 6 outstanding winners of the Infosys Prize

The 6 outstanding winners of the Infosys Prize

Rediff.com7 Jan 2011

The Infosys Science Foundation on Thursday awarded winners of Infosys Prize 2010 recognising their outstanding achievements in scientific research.

Coronavirus: 'Govt needs to allow treatment by private hospitals'

Coronavirus: 'Govt needs to allow treatment by private hospitals'

Rediff.com27 Mar 2020

'We are going to be overwhelmed by the need for hospital beds. There are simply not enough beds in government hospitals.' 'We will need a large number of medical professionals and without the private sector's involvement, the government won't be able to expand capacity.'

Unwarranted to think COVID-19 will vanish in summer: Virologist

Unwarranted to think COVID-19 will vanish in summer: Virologist

Rediff.com11 May 2020

The arrival of summer in India may have raised hopes that hot and humid weather could slow the COVID-19 progression but virologist Naga Suresh Veerapu believes that outbreak and pandemic occurrences often do not follow seasonality.

Infosys on the lookout for acquisitions

Infosys on the lookout for acquisitions

Rediff.com12 Oct 2011

There has been speculation that Infosys is at an advanced stage of talks to buy a US firm operating in the public services and healthcare space.

Dilip Shanghvi bets big on other businesses

Dilip Shanghvi bets big on other businesses

Rediff.com18 Feb 2015

Shanghvi needs to deploy this excess cash.

India cancels orders for Chinese COVID-19 test kits

India cancels orders for Chinese COVID-19 test kits

Rediff.com27 Apr 2020

India procured around 5 lakh rapid antibody test kits from the two Chinese firms, Guongzhou Wondfo Biotech and Livzon Diagnostics, and they were distributed to several states reporting rising cases of the coronavirus infection.

D H Pai Panandiker: An economist from whom even Manmohan Singh used to take advice

D H Pai Panandiker: An economist from whom even Manmohan Singh used to take advice

Rediff.com20 Nov 2018

He did not believe in any fiscal puritanism. In 2012, when it was almost certain that the government will breach the 2012-13 fiscal deficit target, he wrote that in abnormal times, abnormal measures are required to get back to normalcy.

Meet the 6 winners of Infosys Prize

Meet the 6 winners of Infosys Prize

Rediff.com25 Oct 2010

The Infosys Science Foundation on Monday announced the winners of the Infosys Prize 2010 recognizing outstanding contributions to scientific research that have impacted India.

Daiichi shifts 6 early drug programmes to India

Daiichi shifts 6 early drug programmes to India

Rediff.com7 Feb 2011

Daiichi Sankyo, Japan's third-largest drug maker, has transferred six of its early drug discovery programmes in inflammatory and infectious diseases from its Japanese research & development (R&D) facilities to India.

5th top-level exit hits Infosys

5th top-level exit hits Infosys

Rediff.com22 Oct 2018

The latest one being Ken Toombs, global head of consulting at the Bengaluru-based entity.

India Inc to offer 10.3% pay hike to employees

India Inc to offer 10.3% pay hike to employees

Rediff.com13 Apr 2014

Indian companies are likely to shell out an average salary increment of 10.3 per cent in the current fiscal with employees in pharma, health care and life sciences projected to get 12.4 per cent raise, says a survey.

Kerala IT firms eye Nordic markets

Kerala IT firms eye Nordic markets

Rediff.com17 Aug 2010

India will prefer to voluntarily surrender the grant it receives from United Kingdom if the British government decided on cutting it, Finance Minister Pranab Mukherjee told Rajya Sabha on Tuesday.

Want a high paying job? Here's what you should specialise in

Want a high paying job? Here's what you should specialise in

Rediff.com20 Feb 2019

Global companies, e-commerce platforms and software product firms all want skilled digital workers.

Utah nonprofit honours Dr Dinesh Patel

Utah nonprofit honours Dr Dinesh Patel

Rediff.com4 Nov 2010

Utah Youth Village presented its highest honour, the 2010 Helping Hand award, to nationally recognised life sciences innovator Dr Dinesh Patel for his 'extraordinary love and support for Utah's most vulnerable children.'